Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Singular Genomics Sys Q3 2023 EPS $(0.31) Beats $(0.38) Estimate, Sales $462.00K Miss $1.27M Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:28pm
Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.38) by 18.42 percent. This is a 6.06 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $462.00 thousand which missed the analyst consensus estimate of $1.27 million by 63.62 percent.

Posted In: OMIC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist